This page provides information on types of COVID-19 Tests and Supplies for laboratory personnel. This page also provides answers to FAQ’s that pertain to testing types and supplies.… read more »
Category Archives: Coronavirus
CDC’s Diagnostic Multiplex Assay for Flu <em>and</em> COVID-19 and Supplies
CDC’s multiplex assay simultaneously detects influenza A virus, influenza B virus, and SARS-CoV-2, the virus that causes COVID-19.… read more »
CDC Strategy for Global Response to COVID-19 (2020-2023)
Strategy defines CDC program priorities & guides development of criteria for monitoring & evaluating impact for CDC’s global response to the COVID-19 pandemic.… read more »
Information for Laboratories about Coronavirus (COVID-19)
This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).… read more »
COVID-19 Hospitalization and Death by Age
Risk of COVID-19 hospitalization and death by age group… read more »
COVID-19 Hospitalization and Death by Race/Ethnicity
Risk of COVID-19 hospitalization and death by race/ethnicity… read more »
About COVID-19 Vaccine Delivered and Administration Data
CDC is using both new and existing information technology (IT) systems to rapidly collect reliable data about how many doses of COVID-19 vaccines have been delivered (distribution) and how many people have been vaccinated with those doses (administration)… read more »
Health Equity
Systemic health and social inequities have put people from racial and ethnic minority groups at increased risk from COVID-19. Take steps to reduce health disparities.… read more »
COVID-19 Vaccines for Moderately to Severely Immunocompromised People
CDC recommends that moderately or severely immunocompromised people receive an additional dose of mRNA COVID-19 vaccine at least four weeks after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.… read more »